Allosteric modulation of the dopamine D 2 Receptor by Pro-Leu-Gly-NH 2 peptidomimetics constrained in either a Polyproline II Helix or a type II β-turn conformation

Bhooma Raghavan, Kevin J. Skoblenick, Swapna Bhagwanth, Niran Argintaru, Ram K. Mishra, Rodney L. Johnson

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Type II β-turn mimics and polyproline II helix mimics based upon diastereoisomeric 5.6.5 spiro bicyclic scaffolds have provided two pairs of Pro-Leu-Gly-NH 2 (PLG) peptidomimetics with contrasting dopamine receptor modulating activities. Compounds 1a and 3a were found to be positive allosteric modulators of the dopamine receptor, while the corresponding diastereoisomeric compounds 1b and 3b provided the first PLG peptidomimetics with the ability to decrease the binding of agonists to the dopamine receptor. The positive allosteric modulating activity of 3a supported the hypothesis that a polyproline II helix conformation is the bioactive conformation for the PLG analogue Pro-Pro-Pro-NH 2. The results also show that a change in the bridgehead chirality of the 5.6.5 scaffold brings about opposite effects in terms of the modulation of the dopamine receptor.

Original languageEnglish (US)
Pages (from-to)2043-2051
Number of pages9
JournalJournal of medicinal chemistry
Issue number7
StatePublished - Apr 9 2009

Fingerprint Dive into the research topics of 'Allosteric modulation of the dopamine D <sub>2</sub> Receptor by Pro-Leu-Gly-NH <sub>2</sub> peptidomimetics constrained in either a Polyproline II Helix or a type II β-turn conformation'. Together they form a unique fingerprint.

Cite this